surmount-osa tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized trial SURMOUNT-OSA Shows Tirzepatide is Effective

Two large 72-week clinical trials that evaluated terzepatide in individuals who were overweight or obese found that by the end of the study, people who also dieted and exercised reported statistically significant weight loss compared to those who took the placebo

If glutathione is depleted, these reactive intermediates cause severe oxidative damage to the liver's cellular DNA and proteins

By 2030, analysts at Evaluate expect Rezdiffra sales to top $3 billion

GLP-1 medications, such as semaglutide and tirzepatide, play a role by regulating appetite and slowing digestion

Given the investigational nature of low-dose GLP-1 therapy for inflammation, identifying appropriate candidates requires careful clinical judgment and shared decision-making

Semaglutide dosage begins at 0.25mg, then increases to 0.5mg, 1mg, 2mg, and finally 2.5mg